From Vision to Reality: The EU's Pharmaceutical Reforms and the Path to Improved Access
{{output}}
Disparities in access to oncology medicines in European Union (EU) member states can impact patient outcomes profoundly, with availability and timely access varying significantly across and within member states. This paper discusses the intersection of the new... ...
